Copper and zinc metabolism with solid tumor growth

Area of Science:

• Biochemistry
• Oncology
• Trace Element Metabolism

Background:

• Serum copper elevations are historical indicators for hematological neoplasms.
• Copper and zinc metabolism changes are linked to cancer progression and regression.

Purpose of the Study:

• To monitor copper and zinc changes during chemotherapy in breast, colorectal, and lung cancer patients.
• To explore the relationship between copper and zinc levels and tumor growth.
• To investigate copper and zinc metabolism in a solid tumor rat model.

Main Methods:

• Monitoring serum copper and zinc levels in cancer patients undergoing chemotherapy.
• Analyzing copper and zinc levels in a rat mammary adenocarcinoma model.
• Assessing liver enzyme activity related to copper metabolism.

Main Results:

• Elevated serum copper decreased with effective therapy but normalized slowly.
• Serum zinc levels remained markedly below normal in patients.
• In rats, serum copper and zinc varied with tumor mass; liver enzymes showed significant changes.

Conclusions:

• Copper and zinc metabolism are significantly altered during tumor growth.
• Altered copper and zinc levels may serve as indicators of disease progression and treatment response.
• Further research into the clinical significance of these elemental changes is warranted.